Antisense oligonucleotide targeting Bcl-2 messenger RNA in cancer: bad drug, bad target, neither or both?

Ann Oncol. 2009 Mar;20(3):596-7; author reply 597. doi: 10.1093/annonc/mdn772. Epub 2009 Jan 22.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Humans
  • Neoplasms / drug therapy*
  • Neoplasms / genetics
  • Oligonucleotides, Antisense / pharmacology
  • Oligonucleotides, Antisense / therapeutic use*
  • Proto-Oncogene Proteins c-bcl-2 / genetics*
  • RNA, Messenger / genetics*

Substances

  • Oligonucleotides, Antisense
  • Proto-Oncogene Proteins c-bcl-2
  • RNA, Messenger